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Abstract
Brucellosis is a major zoonotic infection in Kazakhstan. However, there is limited data on its
incidence in humans and animals, and the genetic diversity of prevalent strains is virtually
unstudied. Additionally, there is no detailed overview of Kazakhstan brucellosis control and
eradication programs. Here, we analyzed brucellosis epidemiological data, and assessed
the effectiveness of eradication strategies employed over the past 70 years to counteract
this infection. We also conducted multiple loci variable-number tandem repeat analysis
(MLVA) of Brucella abortus strains found in Kazakhstan. We analyzed official data on the
incidence of animal brucellosis in Kazakhstan. The records span more than 70 years of anti-
brucellosis campaigns, and contain a brief description of the applied control strategies, their
effectiveness, and their impact on the incidence in humans. The MLVA-16 method was
used to type 94 strains of B. abortus and serial passages of B. abortus 82, a strain used in
vaccines. MLVA-8 and MLVA-11 analyses clustered strains into a total of four and seven
genotypes, respectively; it is the first time that four of these genotypes have been described.
MLVA-16 analysis divided strains into 28 distinct genotypes having genetic similarity coeffi-
cient that varies from 60 to100% and a Hunter & Gaston diversity index of 0.871. MST
analysis reconstruction revealed clustering into "Kazakhstani-Chinese (Central Asian)",
"European" and "American" lines. Detection of multiple genotypes in a single outbreak con-
firms that poorly controlled trade of livestock plays a crucial role in the spread of infection.
Notably, the MLVA-16 profile of the B. abortus 82 strain was unique and did not change dur-
ing 33 serial passages. MLVA genotyping may thus be useful for epidemiological monitoring
of brucellosis, and for tracking the source(s) of infection. We suggest that countrywide appli-
cation of MLVA genotyping would improve the control of brucellosis in Kazakhstan.
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Introduction
The incidence of brucellosis reaches as much as 200 cases per 100,000 of the population in
some regions of the world; besides, the infection has become endemic in many countries [1].
In addition, brucellosis surveillance data often underestimates the true incidence owing to
diagnostic errors, the diversity of the clinical cases, and concealed official data [2, 3] The
majority of brucellosis cases are registered in Mediterranean countries, South and Central
America, Africa, Asia, Indian subcontinent, Eastern Europe, and the Middle East [4, 5]. Suc-
cessful implementation of an animal vaccination program, in addition to testing and slaughter
of animals which are suspected of (or test positive for) the disease has conferred "officially
bovine brucellosis free" and/or "officially ovine and caprine (Brucella melitensis) free" status on
a number of countries [6]. Control in animals is critical for prevention of spread to humans;
indeed, the majority of human cases in brucellosis-free regions are due to import by people
who have traveled to endemic regions, as they may have had contact with wild animals or with
imported products [7–10]. Local eradication of brucellosis, followed by reduction of control,
may lead to dramatic consequences, as evidenced by re-emergence in Pacific Island Countries
[11], France [12], Malta, and Oman [13]. Continued surveillance of brucellosis in disease-free
area is thus important to prevent re-emergence of the zoonosis [14].
Molecular characterization of circulating strains of Brucella is critical for elimination of
repeated outbreaks, tracking infection spread, and informing selection of anti-brucellosis strat-
egies [15, 16]. Multiple-Locus Variable-number tandem-repeat Analysis (MLVA) is a well-
suited technique for genotyping of Brucella [17–19]. Genotyping of Brucella strains enables dif-
ferentiation between natural and deliberate outbreaks of disease. This is important because the
bacterium is highly contagious in both humans and animals, and the organism can be readily
aerosolized and used as a weapon by bioterrorists; furthermore, the infection is associated with
non-specific symptoms [20–23]. Existing MLVA and Multilocus sequence typing (MLST)
databases for typing of bacteria have greatly facilitated global epidemiologic studies, and inter-
national cooperation aimed at limiting spread of the disease [24–26].
Kazakhstan, a former Soviet republic located in central Eurasia, is in the top twenty five
states with the highest incidence of brucellosis [5]. The country has implemented a number of
brucellosis eradication programs over the past 80 years; however, epidemiological data over
this period is scarce. Therefore, it is hard to infer effectiveness of these activities, and how the
prevalence of brucellosis in animals and humans has changed over time. Finally, there is no
accurate and up to date record of the precise Brucella genotypes in circulation.
Our previous study revealed a low genetic diversity among 124 strains of B. abortus isolated
from animals found in two regions of Kazakhstan. Specifically, the index of genetic diversity
(HGDI) for MLVA-16 was 0.491 [27]. The discriminatory ability of this study was not high
enough for epidemiological monitoring, possibly due to the limited sampling area. To address
this issue, we expanded the sampling area and timeline by including samples from repositories
dating back to 1948. Secondary goals of the current work were to analyze Brucella epidemiol-
ogy in Kazakhstan, and to evaluate the efficacy of current brucellosis eradication programs.
Materials and Methods
Bacterial strains and DNA preparation
A total of 89 B. abortus strains were isolated from different veterinary samples (including
blood, synovia, and aborted fetuses). Twenty-five strains have been isolated between 1943 and
1985 and stored in a repository in a cryopreserved or freeze-dried state with periodic changes
of the liquid selective media. Brucella abortus strain 544 has been stored under the same
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conditions since 1964, and was used to evaluate the genetic stability upon storage. The other
64 strains were collected from seropositive animals detected during routine testing for brucel-
losis in 2015. Strains were cultivated on Brucella Agar with Hemin and Vitamin K (HiMedia
Laboratories) supplemented with 10% horse serum (Sigma-Aldrich) and Brucella Selective
Supplement (HiMedia Laboratories). The strains were identified as Brucella species by the
means of classical identification protocol based on growth inhibition by thionine and basic
fuchsine, in addition to measurement of cytochrome oxidase, catalase, and urease activity
according to the published protocol [28]. The strains collected between 2007 and 2012 were
preserved in cryoprotectant as described elsewhere [29]. Strains collected in 2013 and later
were processed without prior cryopreservation. The National Reference Center for Veterinary
Medicine of the Republic of Kazakhstan (NRCVM) was a sample source and main state reposi-
tory of the selected strains. B. abortus RB51 and B. abortus S19 were used as reference strains
to verify fragment sizes by comparison to the MLVA database. The commercial vaccine strain
B. abortus 82, which is manufactured in Russia, was used to evaluate circulation of vaccine
strains. The provided samples were subjected to DNA isolation using a DNeasy Blood & Tissue
Kit (Qiagen), according to the instructions provided by manufacture. Sequencing of 16S rRNA
gene was performed with universal primers8F (50-AGAGTTTGATCCTGGCTCAG-30) and
806R (50-GGACTACCAGGGTATCTAAT-30) Possible bacterial contamination was also exam-
ined by sequencing [30]. Bruce-ladder PCR was used for species-level identification [31].
MLVA genotyping
The selected MLVA markers were previously reported by Le Flèche et al. [32], and refined by
Al Dahouk et al. [17]. Multiplex PCR and capillary electrophoresis (CE) were carried out as
described by Garofolo et al. with minor modifications [27, 33]. The sixteen pairs of primers
were separated into three panels. Panel 1, also known as MLVA-8, consists of8 loci (Bruce 06,
Bruce 08, Bruce 11, Bruce 12, Bruce 42, Bruce 43, Bruce 45, and Bruce 55). Panel 2A has three
additional loci(Bruce 18, Bruce 19, and Bruce 21), and panel 2B has five extra loci (Bruce 04,
Bruce 07, Bruce 09, Bruce 16, and Bruce 30). Combination of MLVA-8 and 2A loci results in
the MLVA-11 panel, while combination of all three panels (16 loci) results in MLVA-16.
VNTR fragment sizes were automatically calculated by GeneMapper software 4.1 (Applied
Biosystems). Allele calling of multiplexed products was conducted as described previously
[33]. The resulted data were processed with BioNumerics 7.5 software (Applied Maths,).
MLVA-16 profiles of five additional strains were included from our previous study (“key”:
a_1, a_18, a_82, a_112 and a_121) [27], All of them were isolated from cattle between 2007
and 2013 and found to have different genotypes. Cluster analysis was based on the categorical
coefficient and unweighted pair group method using arithmetic averages (UPGMA). Standard
minimum spanning trees (MSTs) were generated using categorical coefficients together with
the single and double locus variance priority rules.
Recent discovery of rare alleles has changed the nomenclature of the locus Bruce 19 and
thus introduced ambiguity; therefore, it was excluded from computation of the MST trees.
HGDI was calculated for polymorphisms at each locus via V-DICE tool available at the HPA
website (http://www.hpa-bioinformatics.org.uk/cgi-bin/DICI/DICI.pl) [34]. The genotypes
were identified by comparison with the May 2016 version of the MLVA database (MLVAbank,
http://microbesgenotyping.i2bc.paris-saclay.fr).
Epidemiology data
A literature search was carried out in March 2016 by means of three electronic databases:
MEDLINE, Google Scholar, and Web of Science, using different combinations of the following
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keywords in titles and/or abstracts: “brucell”, “livestock” “cow OR cattle OR ruminant OR
sheep OR goat OR farm OR smallholding OR collective”. These keywords were combined
with the name of the country: “Kazakh”.
Article title and abstracts were examined for compliance with the search criteria. Full texts
of articles were obtained if they met the selection criteria. Published articles on the epidemiol-
ogy of brucellosis in Kazakhstan in Russian and Kazakh were also included in the search. Offi-
cial statistics on the brucellosis incidence in livestock were taken from the annual reports
issued by "Republican Veterinary Laboratory", as well as reports issued by the "Ministry of
Agriculture of the Kazakh SSR".
Results
Brucellosis incidence and eradication strategies in Kazakhstan
The first case of human brucellosis was recorded in 1932 in the southern regions of Kazakh-
stan. Two years later, brucellosis was reported in central Kazakhstan. Medical expedition to
remote areas with semi-nomadic pastoralism that took place in 1937 revealed a high incidence
of brucellosis among the local population, which indicates that there was a continuous circula-
tion of Brucella in Kazakhstan by this time [35]. However, it is not possible to obtain a com-
plete picture of Brucella dissemination during this period owing to non-systematic record
keeping of brucellosis morbidity at the time. Between 1978 and 1990, the incidence of human
brucellosis in the country ranged from 6.9 to 14.8 cases per 100,000 population, with the sharp-
est rise occurring between 1982 and 1988 (Fig 1).
The first cases of brucellosis in animals were registered in Kazakhstan in 1930 [36], while
planned diagnostic testing for brucellosis was introduced in 1932. The first systematic data
were presented in the annual reports of the Republican veterinary laboratory. The first avail-
able issues date back to 1952 and indicate high infection rates in cattle and sheep of 5.8 and
2.8%, respectively (Fig 2).
Fluctuations in the incidence of animal brucellosis in the Soviet era can be attributed to the
timing of various strategies that were designed to achieve brucellosis eradication. Extensive
vaccination of cattle with the strain B. abortus S19 began in 1955 and provided 70% cattle cov-
erage until 1971. According to epidemiological data, there was a considerable decline in
Fig 1. Incidence of human brucellosis. Time in years is on the x-axis, incidence per 100,000 population is on the y-axis.
doi:10.1371/journal.pone.0167496.g001
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morbidity, which resulted in a reduced number of abortions during this period. Nevertheless,
the level of detection of seropositive animals remained high owing to an inability to discrimi-
nate vaccinated and infected animals, and prolonged preservation of antibrucellar antibody
titer in the vaccinated animals. For this reason, vaccination with strain B. abortus S19 was dis-
continued in 1971 in many regions of the country. This had adverse effects on the epizootic sit-
uation in the country, leading to an increase in seropositive animals that peaked at 4.2% in
1974. Moreover, a deteriorating situation occurred in the northern regions, where there was a
high concentration of animals and a long stall period [37, 38]. Since the mid-70s, B. abortus
strain 82 has been used to vaccinate all groups of cattle along with state-wide test and slaughter
program, which led to a gradual decrease of incidence in herds [39, 40], reaching its minimum
(1.4%) in 1989. Hypothetically, continuation of this combined strategy would eradicate brucel-
losis from cattle.
However, after the fall of the Soviet Union and its economy in 1991, agriculture regulations
became outdated. Large collective farms were de-nationalized, which led to a sharp decline in
the number of livestock and the formation of many small private farms [41]. The previous sys-
tem of veterinary control thus became ineffective. In addition, the difficult economic situation
contributed to the deterioration of the control of many infectious diseases, including brucello-
sis [42]. Officially, the vaccination program continued until 2006; however, the program virtu-
ally collapsed in 1992 due to lack of funding, and shutdown of industrial complexes for
vaccine production that led to an increase in vaccine cost [43]. A coincidence of the circum-
stances thus led to an increase in the number of seropositive cattle to 1.9% in 1995.
Official data associated with this time period are best viewed as highly inconsistent, with
widely fluctuating infection rates. For example, in 2007 only 0.6% of 440,000 animals tested
were diagnosed as seropositive. Since 2007, vaccinations were completely cancelled and
replaced with a new strategy that included total diagnostic coverage of animals using an
enzyme-linked immunosorbent assay (ELISA) and subsequent slaughter of seropositive ani-
mals. Application of ELISA has dramatically increased the detection of seropositive cattle. For
Fig 2. Incidence of animal brucellosis. Time in years is on the x-axis, seroprevalence (%) is on the y-axis.
doi:10.1371/journal.pone.0167496.g002
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example, 2.1% of 5.5 million samples were seropositive in 2009. Despite the subsequent decline
in the number of seropositive animals, voluntary vaccination of cattle was incorporated into
the brucellosis eradication program in 2014. Voluntary vaccination using cattle vaccines regis-
tered in Kazakhstan (B. abortus S19, B. abortus 82, B. abortus RB-51) and sheep vaccine (B.
melitensis Rev1) was permitted. Selection of the vaccine is now the prerogative of the veterinar-
ian and cattle owner, who must notify the State Veterinary Service of their activities. This
introduces an additional burden on the veterinary surveillance system and diagnostic laborato-
ries, both in terms of differentiation of vaccinated and infected animals, as well as the isolation
of bacterial cultures.
Test-and-slaughter of seropositive animals was the main strategy for control of brucellosis
in sheep until the mid-1950s. At this time, sheep population coverage had not reached 50%.
This tactic has therefore had no significant impact on the epizootic situation in the country.
From 1956 to 1974, a brucellosis vaccination campaign (with B. abortus S19 vaccine) was car-
ried out in sheep of any age with a preliminary test-and-slaughter of seropositive cattle. The
campaign led to a 50% reduction in the incidence of sheep brucellosis between 1956 and 1975.
Since 1974, young sheep began to receive the Rev1 vaccine, while the adult population contin-
ued to be vaccinated with B. abortus S19 until 1979. Subsequently, single immunization of
young animals with Rev1 vaccine was adopted. This coincided with a difficult epidemiological
situation when groups of animals of different age were held together. As a result, the strategy
proved to be ineffective, which led to an increase in the brucellosis incidence between 1980
and 1983 that equaled the rates observed in 1953 (Fig 2). In addition, the incidence of human
brucellosis was adversely affected, reaching 14.8 cases per 100,000 individuals. Since 1983,
obligatory vaccination of adult sheep with B. abortus S19 has been introduced. In the late
1980s, Rev 1 vaccine was recommended for immunization of young animals and ewes every
two years. This approach led to a 50% reduction in the number of seropositive animals
between 1983 and 1989.
Since 1991, brucellosis incidence in sheep has declined steadily, and appears to have stabi-
lized at 0.1–0.3% by 2011. Changes in veterinary regulations and control strategy with full cov-
erage testing of livestock, followed by slaughter of seropositive animals have not significantly
affected the level of infection. In contrast to the decline in sheep, the incidence in humans
steadily increased from 11.3 per 100,000 individuals in 1990 to 19.2 per 100,000 in 1992, and
reached a peak (23.95/100,000 people) in 2004 [43]. Afterwards, the incidence of human bru-
cellosis declined steadily, reaching an average of 8.5 cases per 100,000 in 2013. However, the
incidence varies in different regions of the country, with some areas of southern Kazakhstan
reaching up to 150 cases per 100,000 people [44]. Hypothetically, true incidence may be under-
estimated, as the current criteria for infection is very stringent: Brucella growth in culture
medium must be observed in order to identify the subject as positive for the bacterium [43].
Genotyping of Brucella abortus strains using the MLVA16 assay
B. abortus isolates have been collected from 8 regions representing 27 villages; however, not
every isolate collected before 1970 had its precise geographic collection point specified (Fig 3,
S1 Table). Ninety-three strains were isolated from cattle, and one from camel.
The strains from the sample collection were assigned to the genus Brucella based on the
nucleotide sequences analysis of the 16S rRNA gene. There were no overlapping peaks present
in the sequencing chromatograms. Discrimination of Brucella species was based on the Bruce-
ladder PCR. All Brucella samples were identified as Brucella abortus. VNTR analysis of 16 loci
was carried out on all samples. The MLVA profiles from the current work have been uploaded
to an international Brucella MLVA database (http://microbesgenotyping.i2bc.paris-saclay.fr)
Brucellosis in Kazakhstan
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and Figshare repository (https://dx.doi.org/10.6084/m9.figshare.4244477.v1). The genotyping
results were validated by matching the profile of the three reference strains B. abortus S19, B.
abortus RB51, and B. abortus 544. The MLVA-16 profiles of the reference strains were identical
to previously published profiles in the MLVA database. Limited diversity was observed with
MLVA-8 and MLVA-11, Table 1 (HGDI 0.162 and 0.290, respectively). Analysis of the panel
A loci (MLVA-8) revealed four genotypes, with genotype 36 being the most common among
the strains (91%, n = 86). Four strains were found to belong to genotype 28, two strains to
genotype 38, and two strains to genotype 167,which has been detected earlier in Brazil [45].
Three loci that contributed to discrimination in the set of MLVA-8 were Bruce 06 (HGDI of
0.083), Bruce 11, and Bruce 55 with an HGDI of 0.082. MLVA-11 analysis of 94 B. abortus
strains resulted in seven different genotypes. The most common genotype, 72, represented
84% of the strains (n = 79), followed by genotype 70 (6.4%, n = 6), and genotype 82 (4.3%,
n = 4). The other five strains were classified into four different MLVA-11 genotypes that were
not found in the MLVAbank. These genotypes have been submitted to MLVAbank and
recently assigned as genotypes 338 to 341. The Panel 2A locus, Bruce 18, did not have any sig-
nificant discriminatory capacity, and was associated with an HGDI of 0.159. MLVA-16 analy-
sis of the strains resulted in twenty-eight distinct genotypes with genetic similarity coefficient
that varies from 60% to100% (Fig 4).
Fig 3. Geographical representation of Brucella abortus sample collection sites.
doi:10.1371/journal.pone.0167496.g003
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Sixteen of them were represented by single strains, and the associated dendrogram revealed
seven main clades. The first consists of three strains classified as genotypes GtA1-GtA3, while
the second one is the most abundant with 52 strains (genotypes GtA4-GtA14), including a vac-
cine strain of Brucella abortus 82. The third clade consists of 24 strains and 9 genotypes
(GtA15-GtA23). The fourth, fifth, and sixth clades consisted of genotypes GtA24-GtA26 clus-
tered together. The seventh clade was comprised of B. abortus RB51, B. abortus S19, and B.
abortus 544 reference strains, as well as four strains with genotypes GtA27, GtA28. The total
HGDI for all 16 loci was 0.871. All Panel 2B’s loci had high discriminatory potential, with the
highest variability observed at loci Bruce 09 (HGDI 0.779), Bruce 07 (HGDI 0.764) and Bruce
04 (0.553). The Bruce 30 and Bruce 16 loci had only two alleles with HGDI 0.082 and 0.062,
respectively.
The generated MST was based on 94 MLVA-15 profiles of the B. abortus strains from the
current study, and 769 strains of B. abortus from the MLVA bank (Fig 5). MST analysis recon-
struction revealed clustering of ninety strains (earlier classified as I–VI clades) with the strains
prevalently circulating in countries of Europe and Asia, including Italy, Germany, France,
some areas of Portugal, and China. Interestingly, dominant strains in China are arranged in
the lower part of the cluster, forming a single group with the clade III strains. European strains
are arranged in the upper part of the cluster with clades I, II, and IV–VI strains. The MLVA
profile of clade VII strains was identical to that of strains from Brazil and the United States;
these latter strains clustered with those from America, Korea, and Portugal. Eighteen
Table 1. Allelic types and HGDI of B. abortus strains for 16 loci in this study.
Locus B. abortus
Diversity Index Confidence Interval Ka max (pi)b
Panel 1
Bruce 06 0.083 0.007–0.160 3 0.957
Bruce 08 0.000 0.000–0.074 1 1.000
Bruce 11 0.082 0.008–0.157 2 0.957
Bruce 12 0.000 0.000–0.074 1 1.000
Bruce 42 0.000 0.000–0.074 1 1.000
Bruce 43 0.000 0.000–0.074 1 1.000
Bruce 45 0.000 0.000–0.074 1 1.000
Bruce 55 0.082 0.008–0.157 2 0.957
Panel 2A
Bruce 18 0.159 0.063–0.255 3 0.915
Bruce19 0.000 0.000–0.074 1 1.000
Bruce 21 0.000 0.000–0.074 1 1.000
Panel 2B
Bruce 04 0.553 0.465–0.640 5 0.617
Bruce 07 0.764 0.705–0.823 9 0.404
Bruce 09 0.779 0.714–0.844 10 0.415
Bruce 16 0.062 0.000–0.129 2 0.968
Bruce 30 0.082 0.008–0.157 2 0.957
MLVA-8 0.162 0.062–0.262 4 0.915
MLVA-11 0.290 0.172–0.408 7 0.840
MLVA-16 0.871 0.816–0.926 28 0.330
aK = Number of alleles observed at this locus in this sample set.
bmax (pi) = Fraction of samples that have the most frequent repeat number in this locus (range 0.0–1.0)
doi:10.1371/journal.pone.0167496.t001
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Fig 4. Cluster analysis for 94 strains of Brucella abortus based on the MLVA-16 dataset. In the
columns, the following data for strains are indicated: Key, serial number for the strain in the MLVA bank; GT,
genotype MLVA16 in this study; MLVA-8 and MLVA-11, genotype numbers associated with the genotypes
corresponding to each strain in the database; region, geographic region (NKR, North Kazakhstan Region;
EKR, East Kazakhstan Region; WKR, West Kazakhstan Region); host, animal host; year, year of isolation.
doi:10.1371/journal.pone.0167496.g004
Brucellosis in Kazakhstan
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Fig 5. Minimum spanning tree for 94 local isolates of Brucella abortus using MLVA-15 data from 769 profiles of B. abortus.
doi:10.1371/journal.pone.0167496.g005
Brucellosis in Kazakhstan
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genotypes in this study (GaA1-GtA7, GtA12-GtA14, GtA16, GtA17 and GtA21-GtA26) repre-
senting 39 (41.5%) strains had unique profiles that have no match with MLVAbank profiles.
MST analysis revealed clustering of the other 55 (58.5%) strains with genotypes circulating in
Italy (GtA9-GtA11 and GtA20) [46], Portugal (GtA8 and GtA9) [47], and China (GtA10,
GtA15, GtA18, GtA19) [48].
It is evident that a number of genotypes have been circulating in Kazakhstan for a long
time. For example, genotype GtA8 was in circulation in the Almaty region in the 1960s, and
was detected in the West Kazakhstan region as recently as 2015 (Figs 3 and 4, S1 Table). Geno-
type GtA15 was identified in the Almaty region in the 1950s, and emerged again in 2007. In
addition, the genotype was detected in Atyrau region in 1969. Genotype GtA16 has been
found in three areas between 1948 and 2011. Interestingly, strains belonging to the “American”
lineage with MLVA-8 genotype 28 were not detected after 1985.
In some cases, several genotypes could be linked to specific places. For example, GtA25,
GtA7, and GtA22 were isolated strictly in the West Kazakhstan region, while two strains with
the new MLVA-8 genotype were isolated in two unrelated outbreaks in Karaganda region.
Thirty-one strains with genotype GtA11 were identified in a cattle breeding farm at the Tasty
village in the Akmola region during the disease outbreak (June-October 2015). This outbreak
also revealed 4 strains belonging to three different genotypes (Gta12, Gta9, and Gta10).
The MLVA-16 profile of vaccine strain B. abortus 82 was not 100% identical to the strains
from this study, or to strains deposited in MLVAbank prior to May 2016. Genetically related
strains that were isolated in Italy, China, and in our current study differed from the vaccine
strain in Bruce 07 and Bruce 09 loci by 1–3 repeats. The loci of two vaccine strains of B. abortus
82 that we tested were highly stable, as they did not change over 33 consecutive passages in cul-
ture. One of these strains was purchased as a vaccine (Kursk Biofactory, Russia), while the sec-
ond was kept in a depository of NRCVM (unpublished data).
Discussion
The post-Soviet republics of Central Asia, including Kazakhstan, are considered hyperendemic
regions for brucellosis [5]. Brucellosis in humans and animals is highly prevalent in Kazakh-
stan with the incidence being especially elevated in its southern and south-eastern provinces,
where economic role of ruminant livestock is vital. Besides, 62 species of wild mammals in
Kazakhstan are estimated to be seropositive for brucellosis [49].
Despite a century-long history of anti-brucellosis campaigns, Kazakhstan has not overcome
this public health threat. According to official data, the best results have been achieved in
sheep, where brucellosis has almost been eradicated via vaccination of young and adult popu-
lation. A combination of the test-and-slaughter strategy and vaccination program reduced the
incidence of sheep brucellosis to 1% by the beginning of the 1990s, and this most likely con-
tributed to a decrease in the human brucellosis incidence. Over the following twenty years, the
incidence of seropositive sheep dropped to 0.1%, which is close to the level of non-specific
error [43]. Interestingly, this finding contradicts medical data, which states there have been
19,145 reported human cases of brucellosis over the past 10 years in Kazakhstan, or an average
of 1,900 new cases annually (unpublished data). Notably, 99.9% of these cases were caused by
B. melitensis, indicating that sheep were a main source of infection. However, B. abortus seems
to be present as well, especially when the highest seroprevalence rates were reported in ani-
mals, [50]. Among the factors that contribute to the human brucellosis burden in the post-
Soviet period is the increased number of people employed in sheep breeding. Approximately
7- to 8-fold more people are now involved in sheep breeding when compared to the period
in which Kazakhstan was a Soviet republic state. Another reason is that the use of state
Brucellosis in Kazakhstan
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slaughterhouses has been replaced by home slaughter[43]. The incidence of brucellosis in cat-
tle is not constant, and changes immediately in response to eradication strategies. Currently,
there is no single approved strategy to fight brucellosis, as evidenced by the constant changes
in strategy formulation. Regardless of this, and of the government’s efforts to detect infected
animals, the uncontrolled trade in animals is considered the main source of herd incidence
[51, 52]. Therefore, genetic fingerprinting of isolated strains can have a significant impact on
outbreak control, and can facilitate the investigation of infection distribution.
In the current study MLVA-16 was used to assess the genetic diversity among strains of B.
abortus collected from different regions of Kazakhstan since 1943. The combined analysis of
16 VNTR markers revealed a high level of genetic diversity (HGDI, 0.871). Attributable to
the broader geographical coverage and temporal sampling interval, this is almost twice the
value that was obtained in an earlier study [27]. Comparison of MLVA-11 profiles with
MLVAbank data revealed four new genotypes. Interestingly, the most common genotype was
MLVA-8 genotype 36, which is distributed throughout Eurasia. Previously published data
indicate a high genetic identity of B. melitensis strains from China and Kazakhstan, indicating
the relevance of geographical proximity and historical interaction between countries in ani-
mal husbandry [53, 54]. Data on genetic diversity of B. abortus strains reveals "Kazakhstani-
Chinese" relationships, as well as the presence of European and several American genotypes.
This is likely due to the large-scale import of pedigree cattle that began at the beginning of
the last century to improve the native breeds of cattle. Specifically, despite their high resis-
tance to infections and adaptability to nomadic pastoralism, the native Kazak breeds were
characterized by low body weight (280–320 kg) and milkability (500–600 kg per lactation)
[55]. It is possible that the “American” lineage of Brucella was been imported with Hereford
cattle from Uruguay or Santa Gertrudis in the United States. Notably, MLVAbank has only
three strains with MLVA-11 genotype 70 that were registered in Germany, while our study
has uncovered six strains isolated in three localities of the West Kazakhstan region. Interest-
ingly, West Kazakhstan has specialized in the breeding of Simmental cattle since the 1930s
when they were imported to from the Ukraine and Russia, and later from Germany and Swit-
zerland [56].
Remarkably, most outbreaks in the current study are characterized by multiple genotypes.
For example, the strains isolated in Budarinskiy village (West Kazakhstan) were classified as
genotypes GtA10 and GtA25 with three hypervariable 2B panel loci (Bruce04, Bruce07, and
Bruce09) and one panel 2A locus (Bruce 18). Another example is an outbreak in Mereyskiy vil-
lage (West Kazakhstan) represented by three major genotypes GtA10, GtA22 and GtA25 with
the same hypervariable loci. Outbreaks in Tasty (Akmola region) were represented by four
genotypes (GtA9-GtA12). The high genetic stability of MLVA-16 markers [31, 57] and
changes in the number of VNTR loci in panels 2A and 2B suggest several sources of infection.
We infer that these data indicate the role that poorly controlled trade of livestock plays in the
emergence of outbreaks. MLVA-16 analysis confirmed the distribution of genotype GtA25 in
West Kazakhstan. According to the epidemiological data, the villages of Budarinskiy and Say-
chinskiy received their heifers from Mereyskiy village six and nine months before brucellosis
outbreaks, respectively. Genotype GtA25 was isolated exclusively from the livestock purchased
in Mereyskiy village, where this genotype had also previously been found. It was not possible
to trace the source of the other genotypes.
The unique profile of the vaccine strain B. abortus 82 and the high stability of the genetic
loci within the MLVA-16 panel suggest that MLVA analysis can be used for primary identifica-
tion of field and vaccine strains. Nevertheless, the search for alternative highly specific discrim-
inatory markers for the vaccine strain is needed, since certain VNTR loci are unstable over
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multiple passages. Unfortunately, their stability under selective pressure exerted by the host
has not been studied [38].
Conclusion
Although Kazakhstan is an endemic area for brucellosis, the epidemiological data on incidence
of the disease in humans and animals is limited. This study represents the first comprehensive
report on brucellosis epidemiology in Kazakhstan over the last 70 years. In addition, this study
shows that the genetic diversity of B. abortus in Kazakhstan is greater than previously reported,
and emphasizes the importance of extending the geographical and temporal coverage of sam-
pling as widely as possible. Certain genotypes are widely distributed from both temporal and
geographical perspectives, while some outbreaks are characterized by strictly defined geno-
types. Globalization and poor control of imported animals can significantly affect the distribu-
tion of genotypes as evidenced by the circulation of European, Asian, and American lines. We
recommend that epidemiological surveillance should be improved, and that MLVA analysis
should be introduced into veterinary control measures, as this will allow the tracking of the
geographical location of genotypes. Moreover, when compared with routine biotyping, it will
permit the differentiation of field and vaccine strains, and will reduce the risk of infection of
personnel.
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